Utilidad del índice neutrófilo / linfocito como marcador asociado a psoriasis severa en pacientes del Hospital Regional Docente de Trujillo
No Thumbnail Available
Date
2024-12-18
Authors
Mariños Malón, Angie Priscila
Journal Title
Journal ISSN
Volume Title
Publisher
Universidad Nacional de Trujillo
Abstract
La psoriasis es una enfermedad inflamatoria y crónica cutánea que se presenta a cualquier edad. Está asociada a varias condiciones médicas importantes, dentro de ellas a las enfermedades cardiometabólicas, por lo que es necesario un enfoque integral en su tratamiento. El estudio de nuevos biomarcadores como el índice neutrófilo/linfocito busca predecir la severidad de la enfermedad permitiendo un manejo adecuado desde el diagnóstico además de anticipar la respuesta a la terapia lo que falicitaría la implementación de estrategias que optimicen el tratamiento en los servicios de salud. El índice neutrófilo/linfocito es un biomarcador inflamatorio accesible, rápido, no invasivo y de fácil medición que podría desempeñar un papel fundamental no solo en la evaluación de la gravedad de la psoriasis sino también en la valoración de la efectividad de los tratamientos.
Palabras clave: Psoriasis, Biomarcadores, Asociación, Índice de severidad de la enfermedad
Psoriasis is a chronic inflammatory skin disease that occurs at any age. It is associated with several important medical conditions, including cardiometabolic diseases, so a comprehensive approach to its treatment is necessary. The study of new biomarkers such as the neutrophil/lymphocyte ratio seeks to predict the severity of the disease, allowing adequate management from diagnosis in addition to anticipating the response to therapy, which would facilitate the implementation of strategies that optimize treatment in health services. The neutrophil/lymphocyte ratio is an accessible, rapid, non-invasive and easily measured inflammatory biomarker that could play a fundamental role not only in evaluating the severity of psoriasis but also in assessing the effectiveness of treatments.
Psoriasis is a chronic inflammatory skin disease that occurs at any age. It is associated with several important medical conditions, including cardiometabolic diseases, so a comprehensive approach to its treatment is necessary. The study of new biomarkers such as the neutrophil/lymphocyte ratio seeks to predict the severity of the disease, allowing adequate management from diagnosis in addition to anticipating the response to therapy, which would facilitate the implementation of strategies that optimize treatment in health services. The neutrophil/lymphocyte ratio is an accessible, rapid, non-invasive and easily measured inflammatory biomarker that could play a fundamental role not only in evaluating the severity of psoriasis but also in assessing the effectiveness of treatments.
Description
Keywords
Psoriasis, Biomarcadores, Asociación, Índice de Severidad de la Enfermedad